AR-2304 Small Molecule Collaboration

NASH

Current Stage: Lead Optimization

Hit Discovery

Lead Optimization

Preclinical

Clinical

Indication (EN)

NASH

Modality

Small Molecule

Program Type

Collaboration

Interested in Collaboration?

If this program aligns with your therapeutic area, we would be glad to explore partnership opportunities.

Contact Us bd@arontier.co

Back to Pipeline